Steba Biotech Overview
Steba Biotech is a biotechnology company focused on targeting cancer with a minimally invasive approach using a specialmolecule and focused light. Steba is utilizinga novel molecule, focal vascular occluding agent (FVOA), licensed from the Weizmann Institute, in its TOOKAD Soluble drug. TOOKAD Soluble acts as a sensitizer and works with a focused light beam to destroy early-stage prostate cancer cells. The light is delivered to the site through a thin optical fiber. Once the sensitizer is activated by the light, it triggers a process that ultimately cuts off the blood supply to the tumors. Steba Biotech is a private company with its headquarters in Luxembourg and branch companies in France, Israel, USA, Brazil and Switzerland.
Latest News
No news articles.
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | — |
| Rounds | — |
| Investors | — |
Team Members
0
Web & Social Links
| Website | impactbiotech.com |
Photos & Videos
No files yet
Steba Biotech Business
Sector
—Target Customer
—Core Technology
—Steba Biotech Financials
Steba Biotech Lifecycle
Steba Biotech News
0 articlesNo news articles.
Steba Biotech Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Steba Biotech Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 89/100 |
| Missing | funding rounds, markets, not claimed |
| Last update | 2019-02-18T00:00:00.000Z |
| Hidden | Pending approval (visible: 0) |